StemCONN2021 Conference Program

Learn more about the speakers here.

Thursday, April 1, 2021

* Times are approximate and subject to change.  Please note that there will be a moderated Q&A session after each speaker.

9:00 a.m.                   Welcome Remarks

                                  In-Hyun Park, Yale University
Generation of Integrated Brain Organoids To Investigate Brain Development And Diseases

                                  Alison O’Neil, Wesleyan University
Modeling ALS With Human Stem Cell Derived Motor Neurons

9:50 a.m.                   Break                                                                          

                                   Se-Jin Lee, UConn, Jackson Lab
Myostatin: A Molecular Rheostat For Muscle Mass

                                  Milt Wallack Awardee: Ann T. Chen Paired histopathological and scRNA-seq analysis reveals a subset of cancer stem cells contributes to glioblastoma invasion

10:45 a.m.                 Break                                                                          

                                  Welcome Back

                                  Doug Melton, Harvard University
Using Stem Cells To Make Designer Islets For Diabetics

                                  Samira Musah, Duke University
Molecular And Biophysical Control Of Stem Cell Fate

12:20                         Closing Remarks

Thursday, April 8, 2021

9:00                           Welcome Back Remarks

Angela Cacace, Arvinas

Application Of Human Stem Cell Models For Drug Discovery In Monogenic Neurologic Diseases

                                  Karolina Palucka, Jackson Lab

Human-Derived Ex Vivo Systems For Studies On Lung Immunity To Respiratory Viruses

                                   Connie Eaves, Terry Fox Lab

Normal And Malignant Stem Cells – Is Conceptual Simplicity Going Beyond Utility?    

Micheal Bronson, 10X Genomics

Exploring Biology Like Never Before with 10X Genomics

 Milt Wallack Awardee seminar, Dea Gorka, UConn.

Silencing of paternal UBE3A by UBE3A-ATS occurs through transcriptional interface

                                  Allen Eaves, StemCell Technologies

Starting a Biotech – Going Over To The Dark Side Or Seeing The Light

12:15 a.m.                 Closing remarks